Clarus Therapeutics Holdings, Inc.
Clarus Therapeutics Holdings, Inc. (CRXT) is a publicly traded company in the Unknown sector. Across all available filings, 15 corporate insiders have executed 41 transactions totaling $20.2M, demonstrating a bearish sentiment with -$20.2M in net insider flow. The most recent transaction on Jun 7, 2022 involved a transaction of 1,922 shares valued at $0.
CRXT Insider Activity Summary
Who Is Buying CRXT Stock?
No significant insider buying has been recorded for CRXT in the recent period.
Who Is Selling CRXT Stock?
No significant insider selling has been recorded for CRXT in the recent period.
Is Clarus Therapeutics Holdings, Inc. Insider Trading Bullish or Bearish?
Based on recent SEC filings, insider sentiment for CRXT is bearish with an Insider Alignment Score of 0/100 and a net flow of -$20.2M. Insiders are reducing their positions, though this can be driven by factors unrelated to company outlook.
CRXT Frequently Asked Questions
Understanding CRXT Insider Activity
Insider trading at Clarus Therapeutics Holdings, Inc. (CRXT) refers to stock transactions made by corporate insiders—executives, directors, and beneficial owners holding more than 10% of the company's shares. These individuals have access to material non-public information and are required by law to report their trades to the SEC within two business days. Currently, 15 insiders are actively trading CRXT stock, having executed 41 transactions in the past 90 days. The most active insider is Associates II Lp Tmp (Executive), who has made 6 transactions totaling $9.5M.
Related Tools
Track Clarus Therapeutics Holdings, Inc. Insider Activity
Get notified when executives and directors at CRXT file new Form 4 transactions